AcelRx Pharmaceuticals Inc. is a leading biopharmaceutical company specializing in the development and commercialization of innovative therapies for acute pain management. With its focus on the advancement of its proprietary sublingual sufentanil platform, AcelRx is at the forefront of providing effective and efficient pain relief options to patients.